Compare Citius Pharmaceuticals Inc (CTXR) vs MasTec Inc (MTZ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Citius Pharmaceuticals Inc vs MasTec Inc — how do they compare? Citius Pharmaceuticals Inc trades at $0.73 (market cap $20.01M), while MasTec Inc trades at $277 (market cap $21.90B). The key difference: MasTec Inc is far larger — about 1094.5× Citius Pharmaceuticals Inc's market cap, and MasTec Inc is trading nearer its 52-week high, Citius Pharmaceuticals Inc nearer its low. Which is the better fit depends on your goals.
| CTXR | MTZ | |
|---|---|---|
Market Cap | $20.01M | $21.90B |
Sector | Health | Technology |
52-Week High | $1.82 | $437.51 |
52-Week Low | $0.48 | $172.51 |
Enterprise Value | $16.23M | $24.81B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Citius Pharmaceuticals Inc
Citius Pharmaceuticals is a late-stage biopharmaceutical company focused on critical care products. Its pipeline includes anti-infectives and targeted immune therapies for conditions like cutaneous T-cell lymphoma.
Read more on CTXR →About MasTec Inc
MasTec, Inc. is a leading infrastructure construction company operating mainly in North America. The company's services cover a diverse range of end-markets, including communications (building fiber and wireless infrastructure), oil & gas, electric power (transmission, distribution, and clean energy), and industrial projects. MTZ provides critical engineering, procurement, and construction (EPC) services that support the expansion and maintenance of essential infrastructure across the continent.
Read more on MTZ →
